The Effect of Gabapentin (Neurentin) and Pregabalin (Lyrica) in Pain Reduction After Photorefractive Keratectomy

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The studied patients will be given randomly one of three following drugs1:Gabapentin2:

Pregabalin or placebo for 3 days after Photorefractive keratectomy surgery. The pain will be measured based on visual analog scale(VAS) on the day of operation and on the 3 rd day (morning, evening) and then compared among three groups.

• Phase: Phase 1

Details

• Lead Sponsor: Shahid Beheshti University of Medical Sciences
• Treatments: Gabapentin; Pregabalin

Criteria

Inclusion Criteria:

• patients candidate for PRK, 17Exclusion Criteria:

• use of any systemic analgesic drugs, drug intolerance, need of systemic or topical administration of NSAIDs or eye drops for allergy and glaucoma, dry eyes, pregnancy, breast feeding